Tenofovirdisoproxilfumarat bør derfor kun bruges til patienter med nedsat nyrefunktion, hvis de potentielle fordele ved behandlingen anses for at veje tungere end de potentielle risici.
Therefore, in patients with renal impairment tenofovir disoproxil fumarate should only be used if the potential benefits of treatment are considered to outweigh the potential risks.